Hutch News

Hutch News

Stories tagged 'Nora Disis'

Breast Cancer Research Foundation funds 8 Fred Hutch/UW Cancer Consortium scientists

Nearly $2M will go toward potential therapies for metastatic disease and better risk reduction through diet and exercise

Nov. 9, 2018 | By Diane Mapes / Fred Hutch News Service

Researchers in the Fred Hutchinson/University of Washington Cancer Consortium received grants totaling nearly $2 million from the Breast Cancer Research Foundation, or BCRF, funding that will continue to fuel their research through 2019. Most of the grants will go toward new therapies for patients with metastatic cancers.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 3, 2017

Fred Hutch's Dr. Slobodan Beronja and colleagues published new findings that show healthy skin cells can fight off the cancerous tendencies of nearby cells that harbor cancer-causing mutations. Dr. Jeremy Roop, a postdoc conducting HIV research in the McElrath Lab and Computational biology in the Bloom Lab, has been named a Damon Runyan Fellow.

View story >


6 questions in cancer immunotherapy

From cancer vaccines to engineered T cells, experts weigh in on the big unknowns

March 18, 2016 | by Susan Keown / Fred Hutch News Service

Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.

View story >


New breast cancer vaccine ‘promising but not ready for prime time’

Vaccine potentially could be used in the majority of breast cancer patients

Dec. 3, 2014 | By Diane Mapes / Fred Hutch News Service

They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. Fred Hutch researchers weigh in and discuss their own breast cancer vaccine-related work.

View story >


Cancer Immunotherapy Trials Network selects member sites

Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies

April 11, 2011

Research institutions at 27 sites across North America have been selected as part of the Cancer Immunotherapy Trials Network, based at the Fred Hutchinson Cancer Research Center. A new initiative in immunotherapy, CITN unites top academic immunologists to conduct multicenter research on therapies that boost patients’ own immune systems to fight cancer.

View story >


$17 million award launches Cancer Immunotherapy Trials Network

Center to lead national, multi-institutional clinical trials effort

Oct. 11, 2010

In an effort to accelerate clinical trials of promising cancer immunotherapies, the National Cancer Institute has awarded a five-year, $17 million grant to the Fred Hutchinson Cancer Research Center Clinical Research Division’s Dr. Mac Cheever to establish a new Cancer Immunotherapy Trials Network.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.